MCA logo
MCA logo



HSA approves Belimumab (Benlysta) for Lupus Nephritis

belimumab for lupus
Belimumab is a fully human IgG1λ recombinant monoclonal antibody directed against B lymphocyte stimulator. Know more about its drug profile

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Antimicrobial antibiotic resistance
Groundbreaking Discovery Unlocks New Pathway to Combat Antibiotic Resistance in Asia

A revolutionary discovery by researchers in Singapore and MIT has uncovered a new bacterial stress signalling system, opening doors to new methods of combatting antibiotic resistance, a growing public health concern. The research team identified an enzyme, RlmN, that rapidly signals for the production of proteins allowing bacteria to adapt and survive. This could help design drugs that prevent this survival response, effectively tackling antibiotic resistance.

Read More »